Patents Assigned to MYRIAD MYPATH, LLC
  • Genes and gene signatures for diagnosis and treatement of melanoma
    Patent number: 11834719
    Abstract: Panels of biomarkers, methods and systems are disclosed for determining gene expression, and diagnosing and treating melanoma.
    Type: Grant
    Filed: May 20, 2021
    Date of Patent: December 5, 2023
    Assignee: MYRIAD MYPATH, LLC
    Inventors: Michael Bryan Warf, Benjamin Roa, Alexander Gutin, Darl Flake
  • GENES AND GENE SIGNATURES FOR DIAGNOSIS AND TREATMENT OF MELANOMA
    Publication number: 20230340615
    Abstract: Panels of biomarkers, methods and systems are disclosed for determining gene expression, and diagnosing and treating melanoma.
    Type: Application
    Filed: February 3, 2023
    Publication date: October 26, 2023
    Applicant: MYRIAD MYPATH, LLC
    Inventors: Michael Bryan WARF, Benjamin ROA, Alexander GUTIN, Darl FLAKE
  • Genes and gene signatures for diagnosis and treatment of melanoma
    Patent number: 11584967
    Abstract: Panels of biomarkers, methods and systems are disclosed for determining gene expression, and diagnosing and treating melanoma.
    Type: Grant
    Filed: February 10, 2020
    Date of Patent: February 21, 2023
    Assignee: MYRIAD MYPATH, LLC
    Inventors: Michael Bryan Warf, Benjamin Roa, Alexander Gutin, Darl Flake
  • GENES AND GENE SIGNATURES FOR DIAGNOSIS AND TREATEMENT OF MELANOMA
    Publication number: 20220098670
    Abstract: Panels of biomarkers, methods and systems are disclosed for determining gene expression, and diagnosing and treating melanoma.
    Type: Application
    Filed: May 20, 2021
    Publication date: March 31, 2022
    Applicant: MYRIAD MYPATH, LLC
    Inventors: Michael Bryan Warf, Benjamin Roa, Alexander Gutin, Darl Flake